Eli Lilly Drug Retatrutide Clinical Trial Results
Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become…
Lilly’s triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial
In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7% of…